NIOX Group Plc (AIM:NIOX)

Market Cap	248.26M -0.4%
Revenue (ttm)	48.70M +16.5%
Net Income	7.00M +89.2%
EPS	0.02 +98.3%
Shares Out	417.94M
PE Ratio	36.22
Forward PE	15.06
Dividend	0.01 (2.08%)
Ex-Dividend Date	May 15, 2025

Volume	1,118,271
Average Volume	651,049
Open	59.60
Previous Close	60.00
Day's Range	57.80 - 59.60
52-Week Range	53.40 - 77.60
Beta	-0.22
RSI	44.97
Earnings Date	Mar 24, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. N...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2006
• Employees: 91
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2025, NIOX Group's revenue was 48.70 million, an increase of 16.51% compared to the previous year's 41.80 million. Earnings were 7.00 million, an increase of 89.19%.